Madrigal Pharmaceuticals (MDGL) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-5.08
-4.02
-2.96
-1.9

Details

Expected EPS
-2.285109
Actual EPS
-5.08
Surprise EPS
-2.79
Surprise Percent
+122.31%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -5.08 per share for Q4 2025.

0 Comments

Share your thoughts